Paterna Biosciences is an in vitro gametogenesis platform company developing in vitro spermatogenesis (IVS) and ovarian follicle maturation technologies to address male and female infertility. Our technology is helping the 250M men globally who make no sperm or poor quality sperm (>$1T market) and the 500M women around the world with too few eggs (>$2T market). Paterna has successfully made sperm in vitro (never achieved before in humans), and demonstrated that these are fertilization competent.